221 related articles for article (PubMed ID: 32568485)
1. [Microbiota, cancer and immune therapy].
Cabezón-Gutiérrez L; Palka-Kotlowska M; Custodio-Cabello S; Villamayor-Delgado ML; Franco-Moreno AI; Khosravi-Shahi P
Rev Med Inst Mex Seguro Soc; 2019 Sep; 57(5):299-306. PubMed ID: 32568485
[TBL] [Abstract][Full Text] [Related]
2. The impact of modulating the gastrointestinal microbiota in cancer patients.
Morkūnas E; Skiecevičienė J; Kupčinskas J
Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
Lau HCH; Sung JJ; Yu J
Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
[TBL] [Abstract][Full Text] [Related]
4. [Gut microbiota and efficacy of cancer therapies].
Vétizou M; Daillère R; Zitvogel L
Biol Aujourdhui; 2017; 211(1):51-67. PubMed ID: 28682227
[TBL] [Abstract][Full Text] [Related]
5. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
[TBL] [Abstract][Full Text] [Related]
6. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
Matson V; Chervin CS; Gajewski TF
Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
[TBL] [Abstract][Full Text] [Related]
7. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
[TBL] [Abstract][Full Text] [Related]
8. Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy.
Huang J; Jiang Z; Wang Y; Fan X; Cai J; Yao X; Liu L; Huang J; He J; Xie C; Wu Q; Cao Y; Leung EL
Curr Opin Pharmacol; 2020 Oct; 54():1-10. PubMed ID: 32619934
[TBL] [Abstract][Full Text] [Related]
9. Diet, Microbiome, and Cancer Immunotherapy-A Comprehensive Review.
Szczyrek M; Bitkowska P; Chunowski P; Czuchryta P; Krawczyk P; Milanowski J
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34203292
[TBL] [Abstract][Full Text] [Related]
10. The gut microbiome, symptoms, and targeted interventions in children with cancer: a systematic review.
Bai J; Behera M; Bruner DW
Support Care Cancer; 2018 Feb; 26(2):427-439. PubMed ID: 29168036
[TBL] [Abstract][Full Text] [Related]
11. Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications.
Valsecchi AA; Ferrari G; Paratore C; Dionisio R; Vignani F; Sperone P; Vellani G; Novello S; Di Maio M
Crit Rev Oncol Hematol; 2024 May; 197():104328. PubMed ID: 38490281
[TBL] [Abstract][Full Text] [Related]
12. The role of the bacterial microbiome in the treatment of cancer.
Yu ZK; Xie RL; You R; Liu YP; Chen XY; Chen MY; Huang PY
BMC Cancer; 2021 Aug; 21(1):934. PubMed ID: 34412621
[TBL] [Abstract][Full Text] [Related]
13. Advances in research on the relationship between the gut microbiome and cancer.
Song P; Wang QB; Liang B; Jiang SJ
Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5104-5112. PubMed ID: 34486684
[TBL] [Abstract][Full Text] [Related]
14. The microbiome and cancer for clinicians.
Picardo SL; Coburn B; Hansen AR
Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
[TBL] [Abstract][Full Text] [Related]
15. The Potential Role of Probiotics in Cancer Prevention and Treatment.
Yu AQ; Li L
Nutr Cancer; 2016; 68(4):535-44. PubMed ID: 27144297
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications.
Guven DC; Aktas BY; Simsek C; Aksoy S
Future Oncol; 2020 Mar; 16(9):497-506. PubMed ID: 32100550
[TBL] [Abstract][Full Text] [Related]
17. Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments.
Brandi G; Frega G
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159348
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.
Carosella ED; Ploussard G; LeMaoult J; Desgrandchamps F
Eur Urol; 2015 Aug; 68(2):267-79. PubMed ID: 25824720
[TBL] [Abstract][Full Text] [Related]
19. Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.
Pitt JM; Vétizou M; Waldschmitt N; Kroemer G; Chamaillard M; Boneca IG; Zitvogel L
Cancer Res; 2016 Aug; 76(16):4602-7. PubMed ID: 27474734
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.
Gori S; Inno A; Belluomini L; Bocus P; Bisoffi Z; Russo A; Arcaro G
Crit Rev Oncol Hematol; 2019 Nov; 143():139-147. PubMed ID: 31634731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]